22 August 2020>: Clinical Research
Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer
Ning Ren 1BCF* , Zhenmin Tian 2CE* , Hongmei Sun 3BD , Xiaofei Lu 4ABCDEF*DOI: 10.12659/MSM.924590
Med Sci Monit 2020; 26:e924590
Figure 1 Expression of dynamin 2 (DNM2) in papillary thyroid cancer (PTC). Expression of DNM2 was investigated in 112 cases of PTC; patients were classified into low (A) and high (B) expression. The immunohistochemistry scores of (A) and (B) were 15.2 and 132.4, respectively.